W. Brade

779 total citations
37 papers, 621 citations indexed

About

W. Brade is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, W. Brade has authored 37 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in W. Brade's work include Chemotherapy-induced organ toxicity mitigation (6 papers), Metabolism and Genetic Disorders (5 papers) and Renal and related cancers (5 papers). W. Brade is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (6 papers), Metabolism and Genetic Disorders (5 papers) and Renal and related cancers (5 papers). W. Brade collaborates with scholars based in Germany, United States and Austria. W. Brade's co-authors include M. Varini, H. Herken, L.S. Hnilica, S. Seeber, P. Hilgard, J.F. Chiu, H. J. Merker, Jen‐Fu Chiu, R. L. Nelson and Richard W. Dyke and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Analytical Biochemistry.

In The Last Decade

W. Brade

36 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Brade Germany 14 217 197 173 98 73 37 621
Reba K. Wright United States 16 247 1.1× 184 0.9× 94 0.5× 80 0.8× 86 1.2× 28 674
Glenn Tisman United States 16 168 0.8× 91 0.5× 179 1.0× 166 1.7× 45 0.6× 33 788
T. Cerny Switzerland 19 239 1.1× 337 1.7× 347 2.0× 156 1.6× 79 1.1× 36 890
Judit Kralovánszky Hungary 15 138 0.6× 88 0.4× 266 1.5× 98 1.0× 70 1.0× 49 511
Veronica Triaca United States 10 256 1.2× 262 1.3× 101 0.6× 109 1.1× 157 2.2× 20 736
K Becker United States 9 289 1.3× 59 0.3× 114 0.7× 45 0.5× 86 1.2× 16 674
Owens Ah United States 11 110 0.5× 46 0.2× 156 0.9× 74 0.8× 31 0.4× 21 550
Nicholas Armitage United Kingdom 7 93 0.4× 103 0.5× 201 1.2× 85 0.9× 103 1.4× 12 530
Chan H. Park United States 14 351 1.6× 126 0.6× 170 1.0× 128 1.3× 107 1.5× 22 783
Myers Ce United States 8 171 0.8× 43 0.2× 119 0.7× 67 0.7× 102 1.4× 14 516

Countries citing papers authored by W. Brade

Since Specialization
Citations

This map shows the geographic impact of W. Brade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Brade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Brade more than expected).

Fields of papers citing papers by W. Brade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Brade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Brade. The network helps show where W. Brade may publish in the future.

Co-authorship network of co-authors of W. Brade

This figure shows the co-authorship network connecting the top 25 collaborators of W. Brade. A scholar is included among the top collaborators of W. Brade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Brade. W. Brade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goren, Marshall P., et al.. (1998). Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.. Journal of Clinical Oncology. 16(2). 616–621. 16 indexed citations
2.
Brade, W., et al.. (1991). Dosing and side-effects of ifosfamide plus mesna. Journal of Cancer Research and Clinical Oncology. 117(S4). S164–S186. 27 indexed citations
3.
Steger, Guenther G., Christian Dittrich, O. Schlappack, et al.. (1988). Toxicity and response to high-dose ifosfamide+mesna as salvage therapy for advanced breast cancer. Journal of Cancer Research and Clinical Oncology. 114(6). 602–604. 9 indexed citations
4.
Schulz, Peter J., H Bauer, W. Brade, Andrew Keller, & F. Fittler. (1988). Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells.. PubMed. 48(10). 2867–70. 23 indexed citations
5.
6.
Schneider, Martin, et al.. (1986). Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate. Journal of Cancer Research and Clinical Oncology. 111(2). 110–114. 9 indexed citations
7.
Hilgard, P., et al.. (1983). Ifosfamide—Current aspects and perspectives. Cancer Treatment Reviews. 10. 183–192. 30 indexed citations
8.
Kersten, Wolfgang & W. Brade. (1979). Überempfindlichkeit gegenüber Antibiotika. Infection. 7(S6). S580–S583.
9.
Dyke, Richard W., R. L. Nelson, & W. Brade. (1979). Vindesine a short review of preclinical and first clinical data. Cancer Chemotherapy and Pharmacology. 2(4). 229–32. 19 indexed citations
10.
Walter, Paul F., HH Scheld, & W. Brade. (1978). [Reduction of the infection rate following pacemaker implantation through the perioperative administration of cephalothin].. PubMed. 29(18). 736–9. 1 indexed citations
11.
Brade, W., et al.. (1976). In vivo and in vitro phosphorylation of nuclear proteins in rat liver. Canadian Journal of Biochemistry. 54(1). 86–92. 2 indexed citations
12.
13.
Brade, W., et al.. (1974). Chromatin-bound kinase activity and phosphorylation of chromatin non-histone proteins during early kidney regeneration after folic acid. Experimental Cell Research. 84(1-2). 183–190. 28 indexed citations
14.
Brade, W., et al.. (1974). Rat liver histone modifications and their relationship to DNA-dependent RNA polymerase activities during ?-hexachlorocyclohexane induced liver proliferation. Naunyn-Schmiedeberg s Archives of Pharmacology. 284(1). 39–53. 10 indexed citations
15.
Brade, W., Jen‐Fu Chiu, & Lubomir S. Hnilica. (1974). Phosphorylation of rat liver nuclear acidic phosphoproteins after administration of alpha-1,2,3,4,5,6-hexachlorocyclohexane in vivo.. PubMed. 10(3). 398–405. 3 indexed citations
16.
Brade, W., et al.. (1972). Amino acid incorporating activity and synthesis of free and membrane bound polysomes in the rat kidney after folic acid. Biochemical Pharmacology. 21(10). 1431–1440. 3 indexed citations
17.
Brade, W. & Peter Propping. (1970). Akutes Nierenversagen nach Pteridinapplikation. Journal of Molecular Medicine. 48(20). 1209–1216. 7 indexed citations
18.
Brade, W., H. Herken, & H.-J. Merker. (1970). Regeneration of renal tubular cells after lesion by temporary ischaemia, folic acid, and 2,4,5-triamino 6-styrylpyrimidine. Naunyn-Schmiedeberg s Archives of Pharmacology. 266(1). 95–100. 12 indexed citations
19.
Brade, W. & Peter Propping. (1969). [Regeneration of the kidney after tubular damage by pteridine derivatives].. PubMed. 264(3). 222–222. 1 indexed citations
20.
Brade, W., H. Herken, H. J. Merker, & W. Drescher. (1968). Funktionsstörung und Stimulation des Wachstums der Niere durch Folsäure in hoher Dosierung. Journal of Molecular Medicine. 46(22). 1232–1233. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reba K. Wright Breakdown of academic impact, for papers by Glenn Tisman Breakdown of academic impact, for papers by T. Cerny Breakdown of academic impact, for papers by Judit Kralovánszky Breakdown of academic impact, for papers by Veronica Triaca Breakdown of academic impact, for papers by K Becker Breakdown of academic impact, for papers by Owens Ah Breakdown of academic impact, for papers by Nicholas Armitage Breakdown of academic impact, for papers by Chan H. Park Breakdown of academic impact, for papers by Myers Ce
Rankless by CCL
2026